Ocular Therapeutix Q2 results

Ocular Therapeutix (NASDAQ:OCUL) Q2 results: Revenues: $0.1M; Operating Expenses: $6.0M (+102.2%); Net Loss: ($6.4M) (-106.4%); Loss Per Share: ($2.10) (-76.5%); Quick Assets: $19.9M (+13.9%).

No financial guidance given.

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs